Infections can be caused by viruses, bacteria, fungi, and parasites, leading to various types of infections such as stomach, intestine, lung, respiratory, eye, ear, hospital-acquired, skin, and sexually transmitted infections. Infection control has various applications in healthcare settings, including preventing the spread of infectious diseases, reducing healthcare-associated infections, ensuring a safe environment for patients and healthcare workers, implementing proper hand hygiene practices, promoting vaccination, and implementing sterilization and disinfection protocols to maintain a clean and sterile environment.
According to Data Bridge Market Research, the Infection Control Market accounted at USD 44.7 billion in 2021 and is expected to reach USD 65.04 billion by 2029. The market is expected to grow with a CAGR of 4.8% in the forecast period of 2022 to 2029.
“Rise in the prevalence of hospital-acquired infections (HAIs) boosts the market’s growth”
The infection control market is experiencing growth due to the rising prevalence of hospital-acquired infections (HAIs). HAIs are infections that occur during a patient's stay in a healthcare facility and can have serious consequences. The increasing awareness of HAIs and their impact on patient safety has led to a greater focus on infection control measures. Healthcare facilities are investing in technologies and solutions to prevent and control the spread of infections, driving the growth of the infection control market.
What restraints the growth of the infection control market?
“Increasing outsourcing of sterilization services restraints the market’s growth”
The increasing outsourcing of sterilization services restricts the growth of the infection control market. As more healthcare facilities outsource their sterilization processes to specialized service providers, the demand for in-house infection control solutions may decline. This shift towards outsourcing can be attributed to cost-effectiveness, operational efficiency, and access to advanced technologies. However, it limits the market potential for infection control products and services within healthcare facilities, potentially impacting the growth opportunities for manufacturers and providers in this market segment.
Segmentation: Infection Control Market
The infection control market is segmented on the basis of product, application, distribution channel and end user.
- On the basis of product, the infection control market has been segmented into sterilization products, cleaning and disinfection products, personal protective barriers, endoscope reprocessing products, anti-microbial surfaces, and other infection control products.
- On the basis of application, the infection control market has been segmented into surgical instruments, endoscopes, ultrasound probes, and others.
- On the basis of distribution channel, the infection control market has been segmented into direct tender, third party distributors, and retail sales.
- On the basis of end user, the infection control market has been segmented into hospitals, clinics, medical device companies, pharmaceutical and biotechnology companies, laboratories and others.
Regional Insights: North America dominates the infection control market
North America dominates the infection control market due to the increased efforts made by established companies. Moreover, the market is being positively influenced by the consistent number of strategic partnerships formed by key players. These associations are expected to further drive the growth of the infection control market in the region throughout the forecast period.
Asia-Pacific is projected to observe significant amount of growth during the forecast period of 2022 to 2029 in the infection control market owing to the increasing prevalence of outsourcing organizations. Additionally, the rising healthcare expenditures are expected to contribute to the expansion of the market in the region in the foreseeable future.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/global-infection-control-market
Recent Development
- In May, 2020, Getinge AB introduced the Superfast 20 indicators, Getinge AB aims to enhance patient safety. These indicators, which comply with ISO 11138 standards, offer faster results and can be used with various steam and hydrogen peroxide sterilizers. This product introduction is expected to contribute to the growth of Getinge AB's market share in the global patient safety market.
The Prominent Key Players Operating in the Infection Control Market Include:
- 3M (U.S.)
- STERIS. (U.S.)
- Getinge AB (Sweden)
- Cantel Medical (U.S.)
- MATACHANA GROUP (Spain)
- Ecolab (U.S.)
- BELIMED, INC (Switzerland)
- Cardinal Health. (U.S.)
- Steelco S.p.A. (Italy)
- Reckitt Benckiser Group plc (U.K.)
- Stryker Corporation (U.S.)
- B. Braun Melsungen AG (Germany)
- Covalon Technologies Ltd. (Canada)
- SKYTRON, LLC (U.S.)
- Olympus Corporation (Japan)
- COLTENE Group (Switzerland)
- Pal International (India)
- MELAG Medizintechnik GmbH & Co. KG (Germany)
- Cisa Production S.r.l. Unipersonale (Italy)
- Terragene (U.K.)
- The Clorox Company (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of infection control market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global Infection Control Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
